This trial will evaluate if a combination of remotely supervised brain stimulation and language skills practice can help people living with PPA. No established treatments exist.
- Primary Progressive Aphasia
1 Primary · 9 Secondary · Reporting Duration: Baseline, Month 6
Awards & Highlights
1 Treatment Group
Remotely Supervised tDCS and Word-Naming Practice
1 of 1
30 Total Participants · 1 Treatment Group
Primary Treatment: Remotely Supervised tDCS and Word-Naming Practice · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 45 - 80 · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
What site did they apply to?
|NYU Langone Health||100.0%|
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Frequently Asked Questions
Is this clinical experiment open to individuals aged 55 and above?
"This medical trial's eligibility criteria necessitates that applicants be between 45 and 80 years old." - Anonymous Online Contributor
Who is eligible to take part in this research initiative?
"This clinical trial is searching for 30 participants with primary progressive aphasia (PPA) between 45 and 80 years old. To be eligible, they must have a PPVT score that falls below -1 standard deviation, WAIS-IV Matrix Reasoning T score lower than 20, English language fluency sufficient to take part in the study procedures, stable internet access and email service (WiFi "hotspot" provided if necessary), diagnosis of PPA's logopenic or semantic variant." - Anonymous Online Contributor
How many participants are receiving treatment through this investigation?
"Affirmative. According to the clinicaltrials.gov website, this medical study is currently recruiting patients who meet its criteria - with a total of 30 needed from one site. This trial was initially posted on November 1st 2022 and most recently edited on November 8th 2022." - Anonymous Online Contributor
Has the FDA authorized Remotely Supervised tDCS and Word-Naming Practice?
"According to our team at Power's assessment, the safety of Remotely Supervised tDCS and Word-Naming Practice is estimated as a 2 due to this being a Phase 2 trial. This indicates there are some data points supporting its security but none that demonstrate efficacy." - Anonymous Online Contributor
Are there any active recruitment opportunities for this clinical trial?
"Affirmative. As per information on clinicaltrials.gov, this trial is actively welcoming patients to take part in its research. The investigation was first publicized on November 1st 2022 and has been revised most recently on the 8th of that same month. Only 30 individuals need to be enrolled from a single medical facility." - Anonymous Online Contributor